Member: Christin…
Member: Christin OlofssonAlternate: Adam Andersson Medical Products AgencyDag Hammarskjölds väg 42SE-751237 UPPSALA
Member: Christin OlofssonAlternate: Adam Andersson Medical Products AgencyDag Hammarskjölds väg 42SE-751237 UPPSALA
Member: Vlasta Zavadova Office of HealthÄulestrasse 51LI-9490 Vaduz
The ICH Q3E draft “Guideline for Extractables and Leachables” and supporting document has reached Step 2b of the ICH Process on 1 August 2025 and entered the Step 3 public consultation period.
WarfarinDate of publication: 08/08/2025
Piperacillin/tazobactamDate of publication: 08/08/2025
LoperamideDate of publication: 08/08/2025
LinezolidDate of publication: 08/08/2025
LevosimendanDate of publication: 08/08/2025
LactuloseDate of publication: 08/08/2025
GliclazideDate of publication: 08/08/2025